The mechanism involves the enhancement of its substrate AMPK binding by the GDH1 product α-KG that activates CamKK2 to generate energy, resulting in anti-anoikis and ultimately promoting metastasis of lung cancer (54). Here, GLUD1 is linked to lung carcinoma.